Table 3.
New Bone | Xenograft | Soft Tissues | Osteoclastic Zones | Vessels | Inflammatory Infiltrate | |
---|---|---|---|---|---|---|
2 Weeks DBBM | 1.8 ± 4.5 | 59.8 ± 8.6 * | 34.3 ± 6.9 * | 1.6 ± 1.6 | 2.1 ± 1.8 | 0.3 ± 0.9 |
2 Weeks Collagenated | 0.1 ± 0.2 | 50.0 ± 6.3 * | 46.0 ± 6.5 * | 1.2 ± 0.5 | 2.4 ± 1.1 | 0.4 ± 0.4 |
p value | 0.902 | 0.048 | 0.032 | 0.571 | 0.470 | 0.210 |
4 Weeks DBBM | 11.9 ± 6.0 | 51.5 ± 14.9 * | 31.3 ± 7.5 * | 0.0 ± 0.0 * | 5.4 ± 4.1 | 0.0 ± 0.0 * |
4 Weeks Collagenated | 10.2 ± 18.2 | 21.0 ± 19.7 * | 55.8 ± 16.2 * | 5.2 ± 2.8 * | 6.5 ± 5.9 | 1.4 ± 1.4 * |
p value | 0.149 | 0.013 | 0.007 | 0.002 | 0.719 | 0.022 |
8 Weeks DBBM | 23.2 ± 12.8 | 48.3 ± 7.0 * | 27.8 ± 7.0 * | 0.2 ± 0.4 | 0.6 ± 0.8 * | 0.0 ± 0.0 * |
8 Weeks Collagenated | 25.1 ± 8.0 | 5.6 ± 3.2 * | 56.2 ± 12.8 * | 1.3 ± 2.5 | 10.1 ± 4.9 * | 1.6 ± 2.0 * |
p value | 0.764 | <0.0001 | 0.001 | 0.216 | 0.006 | 0.022 |
* p < 0.05 between deproteinized bovine bone mineral (DBBM) and collagenated corticocancellous porcine bone (collagenated) groups.